论文部分内容阅读
随着市场经济制度的不断完善,经济发展速度越来越快,对于集团公司而言,其成本控制问题也逐渐凸显出来。中国宝安集团股份有限公司是以房地产、生物医药、高新技术为主的综合类股份制集团公司,属于上市公司。所以本文主要针对上市公司的成本控制问题进行论述,阐述了成本控制的含义及意义,对上市公司成本控制现状及不足进行了探讨,最后提出了上市公司成本控制的对策。
With the continuous improvement of the market economy system, the economy is growing faster and faster, and for the group companies, the issue of cost control gradually becomes more prominent. China Baoan Group Co., Ltd. is an integrated joint-stock group company mainly engaged in real estate, biomedicine and high-tech. It belongs to the listed company. Therefore, this article mainly discusses the cost control of listed companies, elaborates the meaning and significance of cost control, discusses the status quo and deficiencies of cost control of listed companies, and finally puts forward the countermeasures of cost control of listed companies.